10-Q - Q2/2020

Company

CytomX Therapeutics, Inc.

Filed

August 6, 2020

Period of Report

June 30, 2020

Accession Number

0001564590-20-037722

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →